These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31629863)

  • 1. The effect of antibiotics on the composition of the intestinal microbiota - a systematic review.
    Zimmermann P; Curtis N
    J Infect; 2019 Dec; 79(6):471-489. PubMed ID: 31629863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Four Antibiotics on the Diversity of the Intestinal Microbiota.
    Huang C; Feng S; Huo F; Liu H
    Microbiol Spectr; 2022 Apr; 10(2):e0190421. PubMed ID: 35311555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
    Platsouka E; Zissis NP; Constantoulaki S; Paniara O
    J Chemother; 1997 Oct; 9(5):336-40. PubMed ID: 9373788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
    Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
    Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance development following surgical site infections.
    Călina D; Docea AO; Rosu L; Zlatian O; Rosu AF; Anghelina F; Rogoveanu O; Arsene AL; Nicolae AC; Drăgoi CM; Tsiaoussis J; Tsatsakis AM; Spandidos DA; Drakoulis N; Gofita E
    Mol Med Rep; 2017 Feb; 15(2):681-688. PubMed ID: 27959419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods.
    Rashid MU; Zaura E; Buijs MJ; Keijser BJ; Crielaard W; Nord CE; Weintraub A
    Clin Infect Dis; 2015 May; 60 Suppl 2():S77-84. PubMed ID: 25922405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrapartum antibiotics on the intestinal microbiota of infants: a systematic review.
    Zimmermann P; Curtis N
    Arch Dis Child Fetal Neonatal Ed; 2020 Mar; 105(2):201-208. PubMed ID: 31296695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial.
    Reyman M; van Houten MA; Watson RL; Chu MLJN; Arp K; de Waal WJ; Schiering I; Plötz FB; Willems RJL; van Schaik W; Sanders EAM; Bogaert D
    Nat Commun; 2022 Feb; 13(1):893. PubMed ID: 35173154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.
    Haak BW; Lankelma JM; Hugenholtz F; Belzer C; de Vos WM; Wiersinga WJ
    J Antimicrob Chemother; 2019 Mar; 74(3):782-786. PubMed ID: 30418539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z; Chen M; Yu Y; Pan S; Liu Y
    Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of solithromycin against anaerobic bacteria from the normal intestinal microbiota.
    Weintraub A; Rashid MU; Nord CE
    Anaerobe; 2016 Dec; 42():119-122. PubMed ID: 27725229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
    Burdet C; Grall N; Linard M; Bridier-Nahmias A; Benhayoun M; Bourabha K; Magnan M; Clermont O; d'Humières C; Tenaillon O; Denamur E; Massias L; Tubiana S; Alavoine L; Andremont A; Mentré F; Duval X;
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of infection pathogen resistance in a urological clinic for selection of antibacterial therapy regimes for the treatment of complicated urinary infections].
    Lopatkin NA; Derevianko II; Nefedova LA; Lavrinova LN; Prudnikova SA
    Antibiot Khimioter; 2001; 46(6):21-6. PubMed ID: 11573320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of antibiotic resistance in bacterial isolates from bacteremic patients.
    Blahová J; Králiková K; Krcméry V; Babálová M; Menkyna R; Glosová L; Knotková H; Lisková A; Molokácová M; Vaculíková A
    J Chemother; 2004 Jun; 16(3):269-72. PubMed ID: 15330324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
    Shinagawa N; Tanaka K; Mikamo H; Watanabe K; Takeyama H; Yokoyama T; Takesue Y; Taniguchi M
    Jpn J Antibiot; 2007 Aug; 60(4):206-20. PubMed ID: 18018418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.